What You Should Know
– Topos Bio has emerged from stealth with $10.5M in seed funding to solve one of the most persistent challenges in medicine: targeting intrinsically disordered proteins (IDPs). The seed funding was led…
Continue Reading
11 February – 13 February | DubaiMedTech World Middle East brings together med tech and health tech investors, entrepreneurs, innovators, and industry leaders from around the world. It’s a unique opportunity to:Explore collaboration and…
Continue Reading
Funding Details
Investors and Capital Structure
Valspring Capital’s leadership of the Series B round reflects growing investor confidence in education technology companies that address federally mandated services. According to AlleyWatch, investors were attracted by three key…
What You Should Know:
– According to PwC’s 2026 Health Services Deals Outlook, the M&A market is set to regain momentum in both deal value and volume after a cooling period in 2025.
– The report…
Continue Reading
What You Should Know:
– Ritten, a leading AI-powered system of record for behavioral health providers, today announced a $35 million USD Series B funding round led by Five Elms Capital with participation from existing investors…
Continue Reading
IPO Subscription Overview
The initial public offering of Nephrocare Health Services, India’s leading dialysis services provider, witnessed a 12 per cent subscription on its opening day Wednesday, reflecting cautious investor sentiment in the healthcare sector….
Recent Stock Performance and Market Disconnect
Bright Horizons Family Solutions (BFAM) has quietly delivered steady revenue and earnings growth, even as the share price has slipped over the past three months. This disconnect between operational…
IPO Launch Details
Nephrocare Health Services, operating under the renowned Nephroplus brand, has officially filed its Red Herring Prospectus (RHP) with the Registrar of Companies, marking a significant milestone in India’s healthcare sector. The company,…
TechBio vs. Biotech—what’s real, what’s hype, and how GenAI is actually changing the lab.In this interview, Kavya Sharman, PhD (Founder & Managing Partner, Phase Capital) breaks down the true differences between techbio and biotech,…
Continue Reading
What You Should Know:
– Cellbyte, the AI-native platform that helps pharmaceutical companies accelerate drug launches, announces that it has raised $2.75 million in seed funding.
– The round was led by Frontline Ventures, with participation from…
Continue Reading
